Patent details

300580 Product Name: Pertuzumab.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300580
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1189641
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300580
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/813/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
04/03/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
08/03/2013
First Marketing Authorization date:
04/03/2013
Grant date:
30/07/2013
Activation date:
23/06/2020
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
08/03/2013
SPC/SPC Extension Expiration Date:
22/06/2025
Lapsed By Expiration Date:
23/06/2025
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
08/03/2013
 
 

 

Name:
Genentech, Inc.
Address:
1 DNA Way, 94080-4990, South San Francisco, California, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
08/03/2013
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
26/25
Publication date:
25/06/2025
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
26/20
Publication date:
24/06/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
2013/32
Publication date:
07/08/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
2013/12
Publication date:
20/03/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
20/02/2024
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
30/07/2013 SPC Documents Certificate SPC 1 PDF /0/8/5/0/0/0400300580/docs/300580_0_supplprotectioncertificate20201002104336190.pdf
30/07/2013 Outgoing Correspondence Outgoing Letter 1 PDF /0/8/5/0/0/0400300580/docs/300580_2_outgoingcorrespondence20130730.pdf
11/03/2013 Outgoing Correspondence Outgoing Letter 1 PDF /0/8/5/0/0/0400300580/docs/300580_5_outgoingcorrespondence20130311.pdf
08/03/2013 Application Form First filed application form 2 PDF /0/8/5/0/0/0400300580/docs/300580_1_applicationform20130308.pdf
08/03/2013 SPC Documents Summary of the characteristics of the product 16 PDF /0/8/5/0/0/0400300580/docs/300580_3_supplprotectioncertificate20201002102426672.pdf
08/03/2013 SPC Documents Marketing Authorization SPC 4 PDF /0/8/5/0/0/0400300580/docs/300580_4_supplprotectioncertificate20201002103637519.pdf